In our case, the triad of sensory neuropathy, pyramidal tract involvement, and posterior column impairment is attributable to AP3B2 expression in the dorsal root ganglia, spinal cord, and cerebral cortex. This evidence concerns the gene AP3B2 and Sensory neuropathy.